Abbott Laboratories (ABT)

Operating profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Operating income (ttm)	US$ in thousands	6,943,000	6,896,000	6,806,000	6,746,000	6,974,000	6,414,000	6,415,000	7,128,000	8,362,000	9,436,000	10,212,000	9,228,000	8,425,000	8,479,000	7,428,000	6,708,000	5,357,000	4,314,000	4,017,000	4,551,000
Revenue (ttm)	US$ in thousands	41,950,000	41,217,000	40,725,000	40,326,000	40,109,000	39,959,000	40,226,000	41,505,000	43,653,000	45,030,000	45,548,000	44,514,000	43,075,000	42,308,000	40,233,000	37,338,000	34,608,000	32,221,000	31,444,000	32,095,000
Operating profit margin		16.55%	16.73%	16.71%	16.73%	17.39%	16.05%	15.95%	17.17%	19.16%	20.95%	22.42%	20.73%	19.56%	20.04%	18.46%	17.97%	15.48%	13.39%	12.78%	14.18%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $6,943,000K ÷ $41,950,000K
= 16.55%

Abbott Laboratories has shown fluctuations in its operating profit margin over the period from March 31, 2020, to December 31, 2024. The operating profit margin started at 14.18% in March 2020 and experienced some variability before reaching a peak of 22.42% in June 2022. However, the margin then declined and fluctuated around the range of 16-18% from December 2022 to June 2024 before dropping slightly to 16.55% by December 31, 2024.

Overall, Abbott Laboratories has demonstrated a relatively stable operating profit margin performance, with some fluctuations throughout the period. It is essential for the company to continue monitoring and managing its operating expenses and revenue generation strategies to maintain a healthy operating profit margin in the future.